The Potential Impact of CAR T-Cell Treatment Delays on Society
Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Impact of Type 2 Diabetes Medication Cost Sharing on Patient Outcomes and Health Plan Costs
An analysis of claims from over 90,000 patients with type 2 diabetes (T2D) demonstrates that increased medication cost sharing is associated with higher rates of hospitalization and increased plan costs.
Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events
Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.
Medication Adherence and Measures of Health Plan Quality
This study examines the association between plan-level measures of health outcomes and medication adherence to assess the viability of adherence as a measure of plan performance.
Did Medicare Part D Reduce Disparities?
This study examined the impact of the Medicare Part D coverage gap on medication use by Hispanics, blacks, and whites with diabetes.
Do Strict Formularies Replicate Failure for Patients With Schizophrenia?
This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.
Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid
Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs.
Measuring the Value of Better Diabetes Management
Impact of Oral Nutritional Supplementation on Hospital Outcomes
Instrumental variables regression analysis indicated that inpatient oral nutritional supplement use decreased length of stay, episode cost, and 30-day readmission probability.
Spending and Mortality in US Acute Care Hospitals
Across the US, adults with major medical conditions were less likely to die in hospitals with higher spending levels, even after adjusting for patient risk.
Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Physician Prescribing Behavior and Its Impact on Patient-Level Outcomes
Physicians prescribe more broadly than commonly perceived. Although most physicians have a favorite drug, they are not reluctant to try new therapies.
Medicare Part D After 2 Years
Coverage under Part D is comparable to that under non–Part D plans with respect to key features likely to be important to Medicare beneficiaries.
Impact of Specialty Drugs on the Use of Other Medical Services
Biologic therapy for rheumatoid arthritis or multiple sclerosis was associated with lower use of some types of medical services within 2 to 3 years of initiation.
Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy
Moving Towards Better Formulary Management
Employee Responses to Health Insurance Premium Increases
A New Method for Determining Patient Payments for Outpatient Drugs
2 Clarke Drive Cranbury, NJ 08512